Targeting NOX enzymes in the central nervous system: therapeutic opportunities. (Q34285497)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643836 AND SRC:MED&resulttype=core&format=json

2 February 2020

title

Targeting NOX enzymes in the central nervous system: therapeutic opportunities (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643836 AND SRC:MED&resulttype=core&format=json

2 February 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643836 AND SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Karl-Heinz Krause

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643836 AND SRC:MED&resulttype=core&format=json

2 February 2020

Vincent Jaquet

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643836 AND SRC:MED&resulttype=core&format=json

2 February 2020

publication date

30 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643836 AND SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643836 AND SRC:MED&resulttype=core&format=json

2 February 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643836 AND SRC:MED&resulttype=core&format=json

2 February 2020

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643836 AND SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

2387-2407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643836 AND SRC:MED&resulttype=core&format=json

Classical inhibitors of NOX NAD(P)H oxidases are not specific.

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

NADPH-oxidase activation and cognition in Alzheimer disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Oxidative stress in ALS: key role in motor neuron injury and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Oxidatively modified proteins in aging and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Critical Review: Assessment of Interferon-β Immunogenicity in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Alignment and Sensitive Detection of DNA by a Moving Interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Small-Molecule Inhibitors of NADPH Oxidase 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Epidemiology and natural history of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

The Development of New Therapeutics for Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Recent developments in the inhibitors of neuroinflammation and neurodegeneration: inflammatory oxidative enzymes as a drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Inhibition of NAD(P)H oxidase reduces fibronectin expression in stroke-prone renovascular hypertensive rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Apocynin administration does not improve behavioral and neuropathological deficits in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Perivascular nitric oxide and superoxide in neonatal cerebral hypoxia-ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

The NMDA receptor hypofunction model of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Interferons in relapsing remitting multiple sclerosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

The role of free radical generation in increasing cerebrovascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Nox5 and the regulation of cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

A novel and specific NADPH oxidase-1 (Nox1) small-molecule inhibitor blocks the formation of functional invadopodia in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Perhexiline Maleate As a Cause of Reversible Parkinsonism and Peripheral Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Dynamic optical imaging of metabolic and NADPH oxidase-derived superoxide in live mouse brain using fluorescence lifetime unmixing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Glia: Initiators and progressors of pathology in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Advanced intercross line mapping suggests that ncf1 (ean6) regulates severity in an animal model of guillain-barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Apocynin attenuate spatial learning deficits and oxidative responses to intermittent hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

A new arthritis therapy with oxidative burst inducers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

The protective role of ROS in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Natalizumab Therapy of Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

New developments in understanding and treating neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Editorial: Genetic mapping--the path of discovery for novel functions of the NOX NADPH oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Past and Present Progress in the Pharmacologic Treatment of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

NOX2 inhibition with apocynin worsens stroke outcome in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Neurobiology of cognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

NOX enzymes as novel targets for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Antioxidant approaches for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Long-term social isolation and medial prefrontal cortex: dopaminergic and cholinergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Cortical inhibitory neurons and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Catching up on schizophrenia: natural history and neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Neuroprotection for ischaemic stroke: an unattainable goal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Advancement of therapies for neuroprotection in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Microglial activation and chronic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Chronic apocynin treatment attenuates beta amyloid plaque size and microglial number in hAPP(751)(SL) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Redox modifier genes in amyotrophic lateral sclerosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Stroke prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Mitoxantrone: benefits and risks in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Therapies for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Oxidative stress biomarkers in sporadic ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Alzheimer's disease: emerging trends in small molecule therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Oxygen radical production and severity of the Guillain--Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Leukocyte oxygen radical production determines disease severity in the recurrent Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Oxygen radical production in leukocytes and disease severity in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Intermittent hypoxia-induced cognitive deficits are mediated by NADPH oxidase activity in a murine model of sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Neuroprotection by the NR3A subunit of the NMDA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Phenothiazine: the seven lives of pharmacology's first lead structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Dual oxidase, hydrogen peroxide and thyroid diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Positional identification of Ncf1 as a gene that regulates arthritis severity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Reactive oxygen species: stuck in the middle of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Reactive oxygen species generated by NADPH oxidase are involved in neurodegeneration in the pilocarpine model of temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Effect of apocynin on ozone-induced airway hyperresponsiveness to methacholine in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

The seeds of neurodegeneration: prion-like spreading in ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Treating multiple sclerosis with fingolimod or intramuscular interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

The neurobiology of isoprostanes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

A key role for the microglial NADPH oxidase in APP-dependent killing of neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Antioxidant therapeutics for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Memantine in moderate-to-severe Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Perhexiline neuropathy: A clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Stroke: roles of B vitamins, homocysteine and antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Diagnosis and treatment of Parkinson disease: molecules to medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Oxidative damage in Parkinson disease: Measurement using accurate biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Activation of NADPH oxidase in Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

NOX enzymes in the central nervous system: from signaling to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Apocynin: molecular aptitudes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Multiple non-psychiatric effects of phenothiazines: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Glucose and NADPH oxidase drive neuronal superoxide formation in stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Apocynin improves outcome in experimental stroke with a narrow dose range

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Effects of apocynin and ethanol on intracerebral haemorrhage-induced brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Diapocynin and apocynin administration fails to significantly extend survival in G93A SOD1 ALS mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Radical changes in multiple sclerosis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Ischemic Stroke Injury Is Reduced in Mice Lacking a Functional NADPH Oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Cognitive decline following major surgery is associated with gliosis, β-amyloid accumulation, and τ phosphorylation in old mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Bioavailability of apocynin through its conversion to glycoconjugate but not to diapocynin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Reactive oxygen species and the brain in sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Comparative pharmacology of chemically distinct NADPH oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Recent developments in approved and oral multiple sclerosis treatment and an update on future treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Significance of marrow-derived nicotinamide adenine dinucleotide phosphate oxidase in experimental ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Excess salt causes cerebral neuronal apoptosis and inflammation in stroke-prone hypertensive rats through angiotensin II-induced NADPH oxidase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Nadph Oxidase Mediates Striatal Neuronal Injury after Transient Global Cerebral Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

The T lymphocyte in experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Alcohol-induced exacerbation of ischemic brain injury: role of NAD(P)H oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Inhibition of NADPH oxidase attenuates vasospasm after experimental subarachnoid hemorrhage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Selective loss of catecholaminergic wake active neurons in a murine sleep apnea model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Oxidative-nitrosative stress in a rabbit pup model of germinal matrix hemorrhage: role of NAD(P)H oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Nox2 Is Determinant for Ischemia-Induced Oxidative Stress and Arterial Vasodilatation: A Pilot Study in Patients With Hereditary Nox2 Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00018-012-1014-5

Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease.

21 January 2018

1 reference

12 December 2020

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

1 reference

12 December 2020

New approaches in the management of multiple sclerosis

1 reference

12 December 2020

Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis

1 reference

12 December 2020

Levels of membrane fluidity in the spinal cord and the brain in an animal model of amyotrophic lateral sclerosis

1 reference

12 December 2020

CNS drug discovery: challenges and solutions

1 reference

12 December 2020

Inflammatory Demyelinating Neuropathies

1 reference

12 December 2020

Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase

1 reference

12 December 2020

From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis

1 reference

12 December 2020

NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington's disease in rats: protective role of apocynin

1 reference

12 December 2020

Modeling stroke in mice - middle cerebral artery occlusion with the filament model

1 reference

12 December 2020

Apocynin attenuates cerebral infarction after transient focal ischaemia in rats

1 reference

12 December 2020

Relationship between reduced nicotinamide adenine dinucleotide phosphate oxidase subunit p22phox gene polymorphism and obstructive sleep apnea-hypopnea syndrome in the Chinese Han population.

1 reference

12 December 2020

SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model

1 reference

12 December 2020

Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors

1 reference

12 December 2020

Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease

1 reference

12 December 2020

NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation

1 reference

12 December 2020

Modulation of NADPH oxidase activation in cerebral ischemia/reperfusion injury in rats

1 reference

12 December 2020

Obstructive sleep apnoea: a clinical review.

1 reference

12 December 2020

Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration

1 reference

12 December 2020

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

12 December 2020

Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol

1 reference

12 December 2020

NADPH oxidase inhibitors: a patent review

1 reference

12 December 2020

NADPH oxidase-mediated oxidative damage to proteins in the postsynaptic density after transient cerebral ischemia and reperfusion

1 reference

12 December 2020

Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barré syndrome

1 reference

12 December 2020

The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells

1 reference

12 December 2020

10.1007/S00018-012-1014-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22643836 AND SRC:MED&resulttype=core&format=json

2 February 2020

1 reference